Skip to main content
Clinical Trials/NCT07201272
NCT07201272CompletedNot Applicable

Ultrasound-Guided Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy: A Randomized Clinical Trial

Tanta University2 sites in 1 country60 target enrollmentStarted: October 1, 2025Last updated:
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
2
Primary Endpoint
Time to the 1st rescue analgesia

Study Overview

Brief Summary

This study aims to compare the ultrasound-guided transversalis fascia plane (TFP) block and intrathecal morphine for postoperative analgesia in patients undergoing total abdominal hysterectomy (TAH).

Detailed Description

Total abdominal hysterectomy (TAH) is a commonly performed major surgical procedure that results in substantial postoperative pain and discomfort. Postoperative pain, if not treated promptly, can impair the patient's ability to ambulate which may lead to adverse effects such as thromboembolism, myocardial ischemia, and arrhythmia.

Intrathecal opioids are synergistic with local anesthetics and intensify the sensory block without increasing the sympathetic block. Morphine, which is relatively less hydrophobic than other opioids, has a longer residence time in the cerebrospinal fluid and therefore may reach rostral sites over a longer period than other opioids.

Ultrasound-guided interfascial plane blocks are often used in multimodal analgesia regimens. Local anaesthetic injection into the transversalis fascia plane (TFP) anesthetizes the proximal branches of T12 and L1 which targeted in the plane between the transversus abdominis muscle and the transversalis fascia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age from 18 to 65 years.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Women undergoing total abdominal hysterectomy (TAH) under spinal anesthesia.

Exclusion Criteria

  • History of allergies to local anesthetics.
  • Local infection at the site of injection.
  • Bleeding disorders.
  • History of chronic use of analgesic.
  • Physical or mental conditions.
  • Hepatic, renal or cardiac disease.
  • Contraindication to spinal anesthesia.

Arms & Interventions

TFP group

Experimental

Patients will receive spinal anesthesia (using 3.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.

Intervention: Transversalis fascia plane block (Other)

IM group

Experimental

Patients will receive spinal anesthesia (using 3 mL of hyperbaric bupivacaine 0.5%) + (75 µg morphine diluted in 0.5ml saline) with sham block at the end of surgery.

Intervention: Morphine (Drug)

Outcomes

Primary Outcomes

Time to the 1st rescue analgesia

Time Frame: 24 hours postoperatively

Time to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).

Secondary Outcomes

  • Total morphine consumption(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)
  • Incidence of adverse events(24 hours postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Study Sites (2)

Loading locations...

Similar Trials